(Q51974572)

19 April 2018

title

Statins prevent cholinesterase inhibitor blockade of sympathetic alpha7-nAChR-mediated currents in rat superior cervical ganglion neurons. (English)

1 reference

19 April 2018

author name string

Mansoor Mozayan

series ordinal

1

1 reference

19 April 2018

Tony J F Lee

series ordinal

2

1 reference

19 April 2018

publication date

8 June 2007

1 reference

19 April 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

19 April 2018

volume

293

1 reference

19 April 2018

issue

3

1 reference

19 April 2018

page(s)

H1737-44

1 reference

19 April 2018

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Effects of post-learning smoking on memory consolidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Cholinergic markers in elderly patients with early signs of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Acetylcholinesterase inhibition in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

The diagnosis of dementia with single photon emission computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

NICE proposes to withdraw Alzheimer's drugs from NHS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

The Ligand Gated Ion Channel Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

NICE recommends drugs for moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Cholinesterase inhibitor blockade and its prevention by statins of sympathetic alpha7-nAChR-mediated cerebral nitrergic neurogenic vasodilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Protective effect of GTS-21, a novel nicotinic receptor agonist, on delayed neuronal death induced by ischemia in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Alpha7-nicotinic acetylcholine receptors on cerebral perivascular sympathetic nerves mediate choline-induced nitrergic neurogenic vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Statins prevent beta-amyloid inhibition of sympathetic alpha7-nAChR-mediated nitrergic neurogenic dilation in porcine basilar arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Allosteric modulation of the nicotinic acetylcholine receptor by physostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00269.2007

10.1152/AJPHEART.00269.2007

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018